Anjos S M, Shao W, Marchand L, Polychronakos C
Endocrine Genetics Laboratory, Department of Pediatrics, Division of Pediatric Endocrinology, The McGill University Health Center (Montreal Children's Hospital), Montréal, Québec, Canada.
Genes Immun. 2005 Jun;6(4):305-11. doi: 10.1038/sj.gene.6364211.
Genetic variation at a linkage disequilibrium block encompassing the cytotoxic T-lymphocyte antigen-4 (CTLA4) gene influences susceptibility to autoimmunity, but identifying the polymorphism(s) responsible for this effect has been challenging. Recently, a single-nucleotide polymorphism (SNP) located 3' to the known polyadenylation site of CTLA4 (+6230G>A) and strongly associated with autoimmune disease was reported to regulate levels of soluble CTLA4 isoform (sCTLA4) but not the full-length isoform. The purpose of the present study is to define the mechanistic effect of the 3'SNP on the isoforms of CTLA4 (alternative splicing vs polyadenylation vs effects on RNA stability). However, using allele-specific single-nucleotide primer extension, we found no difference between mRNA transcripts derived from either +6230G>A allele in 11 heterozygous individuals, in either of the two known CTLA4 isoforms. We also found no effect of this polymorphism on ICOS (inducible costimulator), a putative downstream target. In addition, repeated attempts at 3' RACE (3'rapid amplification of cDNA ends) were unsuccessful in amplifying any contiguous sequence past the known CTLA4 polyadenylation site and no such sequence was found in the EST databases. We conclude that the mechanism of the observed association of the +6230 SNP with autoimmune disease remains to be determined, but does not involve modulation of steady-state mRNA of any known CTLA4 isoform.
包含细胞毒性T淋巴细胞抗原4(CTLA4)基因的连锁不平衡区域的遗传变异影响自身免疫易感性,但确定导致这种效应的多态性一直具有挑战性。最近,据报道,位于CTLA4已知多聚腺苷酸化位点3'端的一个单核苷酸多态性(SNP,+6230G>A)与自身免疫性疾病密切相关,它可调节可溶性CTLA4异构体(sCTLA4)的水平,但不影响全长异构体。本研究的目的是确定该3'SNP对CTLA4异构体的作用机制(选择性剪接、多聚腺苷酸化还是对RNA稳定性的影响)。然而,通过等位基因特异性单核苷酸引物延伸,我们在11名杂合个体中,未发现两种已知CTLA4异构体中源自+6230G>A任一等位基因的mRNA转录本存在差异。我们还发现该多态性对诱导性共刺激分子(ICOS)这一假定的下游靶点没有影响。此外,多次尝试进行3'RACE(3' cDNA末端快速扩增)均未能扩增出已知CTLA4多聚腺苷酸化位点以外的任何连续序列,并且在EST数据库中也未发现此类序列。我们得出结论,+6230 SNP与自身免疫性疾病之间观察到的关联机制尚待确定,但不涉及对任何已知CTLA4异构体稳态mRNA的调节。